109 related articles for article (PubMed ID: 2551058)
1. The effect of low dose of 12-O-tetradecanoyl-phorbol-13-acetate on collagen platelet interactions.
Chiang TM
Thromb Res; 1989 Jun; 54(6):633-41. PubMed ID: 2551058
[TBL] [Abstract][Full Text] [Related]
2. Effects of 12-O-tetradecanoyl phorbol 13-acetate on platelet aggregation.
Chiang TM; Cagen LM; Kang AH
Thromb Res; 1981 Mar; 21(6):611-22. PubMed ID: 6267728
[No Abstract] [Full Text] [Related]
3. Synergism between subthreshold concentrations of thrombin and 12-O-tetradecanoylphorbol 13-acetate in platelet activation.
Yatomi Y; Higashihara M; Tanabe A; Ohashi T; Oka H; Kume S
Biochem Biophys Res Commun; 1987 Nov; 148(3):1025-9. PubMed ID: 3689381
[TBL] [Abstract][Full Text] [Related]
4. The tumor-promoter phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate), a potent aggregating agent for blood platelets.
Zucker MB; Troll W; Belman S
J Cell Biol; 1974 Feb; 60(2):325-36. PubMed ID: 4360292
[TBL] [Abstract][Full Text] [Related]
5. A role for intracellular histamine in collagen-induced platelet aggregation.
Saxena SP; McNicol A; Brandes LJ; Becker AB; Gerrard JM
Blood; 1990 Jan; 75(2):407-14. PubMed ID: 2104768
[TBL] [Abstract][Full Text] [Related]
6. Differences in the mode of action of 1-oleoyl-2-acetyl-glycerol and phorbol ester in platelet activation.
Ashby B; Kowalska MA; Wernick E; Rigmaiden M; Daniel JL; Smith JB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(5):473-83. PubMed ID: 2999204
[TBL] [Abstract][Full Text] [Related]
7. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
8. 3,3',5'-Triiodothyronine inhibits collagen-induced human platelet aggregation.
Masaki H; Nishikawa M; Urakami M; Yoshimura M; Toyoda N; Mori Y; Yoshikawa N; Inada M
J Clin Endocrinol Metab; 1992 Sep; 75(3):721-5. PubMed ID: 1517361
[TBL] [Abstract][Full Text] [Related]
9. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
[TBL] [Abstract][Full Text] [Related]
10. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the diacylglycerol kinase inhibitor R59022 on thrombin versus collagen-induced human platelet secretion.
Joseph S; Krishnamurthi S; Kakkar VV
Biochim Biophys Acta; 1988 Apr; 969(1):9-17. PubMed ID: 2832002
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting platelet cyclic GMP levels during aggregation induced by collagen and by arachidonic acid.
Davies T; Davidson MM; McClenaghan MD; Say A; Haslam RJ
Thromb Res; 1976 Oct; 9(4):387-405. PubMed ID: 185743
[No Abstract] [Full Text] [Related]
13. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
14. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of effects of various drugs on platelet functions using phorbol 12-myristate 13-acetate-induced megakaryocytic human erythroid leukemia cells.
Tada T; Aki K; Oboshi W; Kawazoe K; Yasui T; Hosoi E
Drug Des Devel Ther; 2016; 10():3099-3107. PubMed ID: 27713620
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Sheu JR; Hsiao G; Shen MY; Wang Y; Lin KH; Lin CH; Chou DS
Exp Biol Med (Maywood); 2003 Dec; 228(11):1321-8. PubMed ID: 14681547
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
Matsuoka I; Nakahata N; Nakanishi H
Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
20. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
